Glenmark Pharmaceuticals Limited Share Price Bombay S.E.
Stocks
GLENMARK
INE935A01035
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,287.00 INR | -0.52% |
|
+2.40% | +12.33% |
| 03/08 | Glenmark Pharmaceuticals Limited, Q1 2027 Earnings Call, Aug 03, 2026 | |
| 31/07 | India's Glenmark Pharma posts higher quarterly profit on strong demand | RE |
| Market Cap | 64TCr 675.79Cr 584.56Cr 545.89Cr 500.78Cr 941.89Cr 956.86Cr 6.4TCr 2.51TCr 32TCr 2.54TCr 2.48TCr 1,06600Cr | P/E 2026 |
44.2x | P/E 2027 * | 27.7x |
|---|---|---|---|---|---|
| Enterprise Value | 60TCr 634.51Cr 548.85Cr 512.54Cr 470.18Cr 884.35Cr 898.4Cr 6.01TCr 2.36TCr 30TCr 2.38TCr 2.33TCr 1,00100Cr | EV / Sales 2026 |
3.51x | EV / Sales 2027 * | 3.74x |
| Free-Float |
51.04% | Yield 2026 |
0.12% | Yield 2027 * | 0.17% |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | -0.52% | ||
| 1 week | +2.40% | ||
| Current month | +2.40% | ||
| 1 month | +2.84% | ||
| 3 months | -3.27% | ||
| 6 months | +18.24% | ||
| Current year | +12.33% |
| 1 week | 2,163 |  | 2,299 |
| 1 month | 2,163 | | 2,326 |
| Current year | 1,842.8 | | 2,471.05 |
| 1 year | 1,794 | | 2,471.05 |
| 3 years | 702.05 | | 2,471.05 |
| 5 years | 348.9 | | 2,471.05 |
| 10 years | 168 | | 2,471.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2000 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 27/05/2025 |
Indrajit Bose
PSD | President | - | 15/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 12/05/2011 | |
| Director/Board Member | 85 | 14/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.52% | +2.40% | - | - | 675.79Cr | |
| -0.31% | -2.29% | +22.57% | +69.33% | 4.9TCr | |
| +4.40% | +14.46% | +62.66% | +133.25% | 4.23TCr | |
| -0.89% | -0.64% | -1.48% | +15.58% | 1.24TCr | |
| +0.56% | -1.12% | +19.02% | +70.02% | 1.17TCr | |
| +0.19% | +0.77% | +31.74% | +141.01% | 911.81Cr | |
| +1.99% | +4.41% | +17.56% | +34.79% | 714.94Cr | |
| +1.82% | -0.15% | +39.41% | -13.77% | 709.32Cr | |
| +0.40% | +2.02% | +12.85% | +176.30% | 675.79Cr | |
| +6.44% | +8.26% | -24.61% | +30.64% | 595.19Cr | |
| Average | +1.41% | +2.74% | +19.97% | +73.02% | 1.68TCr | |
| Weighted average by Cap. | +1.47% | +3.75% | +30.34% | +84.87% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 15TCr 160.88Cr 139.16Cr 129.96Cr 119.22Cr 224.23Cr 227.79Cr 1.52TCr 598.44Cr 7.67TCr 604.14Cr 590.91Cr 25TCr | 17TCr 176.44Cr 152.62Cr 142.53Cr 130.75Cr 245.92Cr 249.83Cr 1.67TCr 656.34Cr 8.42TCr 662.58Cr 648.08Cr 28TCr |
| Net income | 2.05TCr 22Cr 19Cr 17Cr 16Cr 30Cr 31Cr 204.46Cr 80Cr 1.03TCr 81Cr 79Cr 3.4TCr | 2.31TCr 24Cr 21Cr 20Cr 18Cr 34Cr 34Cr 230.14Cr 90Cr 1.16TCr 91Cr 89Cr 3.83TCr |
| Net Debt | -3.93TCr -41Cr -36Cr -33Cr -31Cr -58Cr -58Cr -391.29Cr -153.58Cr -1.97TCr -155.04Cr -151.65Cr -6.51TCr | -1.45TCr -15Cr -13Cr -12Cr -11Cr -21Cr -22Cr -144.12Cr -57Cr -725.43Cr -57Cr -56Cr -2.4TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/26/07 | ₹2,287.00 | -0.52% | 18,026 |
| 06/26/06 | ₹2,299.00 | +2.27% | 17,796 |
| 05/26/05 | ₹2,248.00 | +1.31% | 16,578 |
| 04/26/04 | ₹2,219.00 | +1.85% | 15,032 |
| 03/26/03 | ₹2,178.60 | -2.45% | 42,768 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions
